A Randomized Controlled Trial of MetforminversusVitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease

Bugianesi, Elisabetta; Gentilcore, Elena; Manini, Rita; Natale, Stefania; Vanni, Ester; Villanova, Nicola; David, Ezio; Rizzetto, Mario; Marchesini, Giulio
May 2005
American Journal of Gastroenterology;May2005, Vol. 100 Issue 5, p1082
Academic Journal
OBJECTIVES: Metformin proved useful in the treatment of nonalcoholic fatty liver disease (NAFLD), but its superiority over nutritional treatment and antioxidants has never been demonstrated. We aimed to compare the usefulness of metforminversusprescriptive diet or vitamin E.METHODS: In an open label, randomized trial, nondiabetic NAFLD patients were given metformin (2 g/day; n= 55) for 12 months. The control cases were given either vitamin E (800 IU/day; n= 28) or were treated by a prescriptive, weight-reducing diet (n= 27). Outcome measures were liver enzymes, insulin resistance (homeostasis model assessment), parameters of the metabolic syndrome, and histology.RESULTS: Aminotransferase levels improved in all groups, in association with weight loss. The effects in the metformin arm were larger (p<0.0001), and alanine aminotransferase normalized in 56% of cases (odds ratio (OR)versus. controls, 3.11; 95% confidence interval (CI), 1.56–6.20;p= 0.0013). In multivariate analysis, metformin treatment was associated with higher rates of aminotransferase normalization, after correction for age, gender, basal aminotransferases, and change in body mass index (OR, 5.98; 95% CI, 2.05–17.45). Differences were maintained when the two control groups were separately analyzed. The distribution of positive criteria for the metabolic syndrome was reduced only in the metformin arm (p= 0.001, signed rank test). A control biopsy in 17 metformin-treated cases (14 nonresponders) showed a significant decrease in liver fat (p= 0.0004), necroinflammation, and fibrosis (p= 0.012 for both). No side effects were observed during metformin treatment.CONCLUSIONS: Metformin treatment is better than a prescriptive diet or vitamin E in the therapy of NAFLD patients receiving nutritional counseling. Limited histological data support an association between improved aminotransferases and biopsy findings, which require confirmation in a double-blind trial with appropriate statistical power based on liver histology.(Am J Gastroenterol 2005;100:1082–1090)


Related Articles

  • Hypocaloric high-protein diet improves clinical and biochemical markers in patients with nonalcoholic fatty liver disease (NAFLD). Bezerra Duarte, Sebastião Mauro; Faintuch, Joel; Stefano, José Tadeu; Sobral de Oliveira, Maria Beatriz; de Campos Mazo, Daniel Ferraz; Rabelo, Fabiola; Vanni, Denise; Aydar Nogueira, Monize; Carrilho, Flair José; Marques Souza de Oliveira, Claudia Pinto // Nutricion Hospitalaria;ene2014, Vol. 29 Issue 1, p94 

    Objective: To investigate the role of hypocaloric highprotein diet, a prospective clinical study was conducted in NAFLD patients. Research methods and procedures: Pre-versus post-interventional data were analyzed in 48 stable NAFLD patients (submitted to a hypocaloric high-protein diet during 75...

  • ADVANCES IN HEPATOLOGY: Current Developments in the Treatment of Hepatitis and Hepatobiliary Disease. Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis. Kowdley, Kris V. // Gastroenterology & Hepatology;Mar2014, Vol. 10 Issue 3, p184 

    An interview with clinical professor of medicine Kris V. Kowdley is presented. He highlights the use of liver biopsy to differentiate steatosis from nonalcoholic steatohepatitis (NASH), a fatty liver disease. He details several signs of patient with NASH including hypertension, increased waist...

  • Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future. Gitto, S.; Vitale, G.; Villa, E.; Andreone, P. // Gastroenterology Research & Practice;3/18/2015, Vol. 2015, p1 

    Nonalcoholic steatohepatitis has become one of the most common liver-related health problems. This condition has been linked to an unhealthy diet and weight gain, but it can also be observed in nonobese people. The standard of care is represented by the lifestyle intervention. However, because...

  • Nonalcoholic Fatty Liver Disease in Chronic Hepatitis C. Patrick, Lyn // Townsend Letter;Apr2014, Issue 369, p67 

    The article addresses the question of whether all patients with diagnosed nonalcoholic fatty liver disease (NFLD) should be screened for chronic hepatitis C and whether all chronic hepatitis C patients should be screened for NASH (nonalcoholic steatotic hepatitis). In indicates an increased...

  • CORRECTION. Tarantino, Giovanni // Journal of Gastrointestinal & Liver Diseases;Jun2013, Vol. 22 Issue 2, p242 

    A correction to the article "Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients?," by S. Zelber-Sagi and colleagues that was published in the 2012 issue is presented.

  • Right Upper Quadrant Pain and Fever in a 41-Year-Old Man. AaIaei, Sophie; Jakate, Shriram // Archives of Pathology & Laboratory Medicine;May2005, Vol. 129 Issue 5, pe134 

    The article presents information about a case of a 41-year-old male fork-lift operator presented with a 2- year history of recurrent episodes of tight right upper quadrant pain and low-grade fever, each episode lasting up to 10 days. During that time, he also experienced intermittent nausea and...

  • Non-alcoholic fatty liver disease. Jones, Mark // New Zealand Doctor;6/20/2007, p28 

    The article examines the case of a female patient who presented with elevated gamma glutamyl transferase, aspartate aminotransferase and alanine amino transferase and with suspected non-alcoholic fatty liver disease (NAFLD). NAFLD is linked with a number of diseases. There are various causes of...

  • Water Soluble Vitamin E Administration in Wistar Rats with Non-alcoholic Fatty Liver Disease. Tzanetakou, Irene P.; Doulamis, Ilias P.; Korou, Laskarina-Maria; Agrogiannis, George; Vlachos, Ioannis S.; Pantopoulou, Alkisti; Mikhailidis, Dimitri P.; Patsouris, Efstratios; Vlachos, Ioannis; Perrea, Despina N. // Open Cardiovascular Medicine Journal;2012, Vol. 6, p88 

    Objective: A diet rich in fat is associated with hepatic fat deposition [steatosis; non-alcoholic fatty liver disease (NAFLD)]. The exact cause of NAFLD however, is still unknown. The aim of this study was to assess the effect of a water-soluble formulation of vitamin E on a...

  • Effects of pioglitazone on nonalcoholic steatohepatitis in a patient with anorexia nervosa: A case report. TOMOHIKO OHNO; YOICHI NISHIGAKI; TETSUYA YAMADA; YUKO WAKAHARA; HIROYASU SAKAI; KOTARO YOSHIMURA; MASAHITO SHIMIZU; TOSHIO USUI; MASAYA SAITO; ICHIRO YASUDA; HISASHI TSURUMI; EIICHI TOMITA; HISATAKA MORIWAKI // Experimental & Therapeutic Medicine;2014, Vol. 7 Issue 4, p811 

    Diseases associated with metabolic syndromes are of major concern in developed countries. Nonalcoholic steatohepatitis (NASH) is one of the manifestations of metabolic syndrome in the liver. Previous studies have shown that NASH is also caused by malnutrition. In the present study, a case of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics